P/E ratio for OPKO Health (OPK)

P/E ratio history for OPKO Health from 2001 to 2023

PE ratio at the end of each year

P/E ratio for similar companies or competitors

Company	P/E ratio	P/E ratio differencediff.	Country
Johnson & Johnson JNJ	10.3	-278.35%	🇺🇸 USA
Abbott Laboratories ABT	38.5	-768.53%	🇺🇸 USA
Regeneron Pharmaceuticals REGN	19.0	-429.85%	🇺🇸 USA
Teva Pharmaceutical Industries TEVA	-11.0	91.02%	🇮🇱 Israel
Alnylam Pharmaceuticals ALNY	-59.8	937.51%	🇺🇸 USA
Bristol-Myers Squibb BMY	14.3	-347.68%	🇺🇸 USA
LabCorp LH	30.4	-627.05%	🇺🇸 USA
Ardelyx ARDX	-40.2	597.38%	🇺🇸 USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.